Cellumium Foundation
A foundation in Singapore is proposed to oversee token issuance and burn policy. Its incorporation and schedule are unconfirmed.
- Issuance & burn policy
- On-chain disclosure of policy changes
Cellumium explores aging and recovery through Professor Phan Toan Thang’s research on umbilical cord lining stem cells.
Care is delivered by partner medical institutions. Skin analysis is a preview; the Data Lab is in preparation.
Explore the Cellumigen program, try the skin analysis preview or read the plans for the Data Lab.
A premium care tour run with a partner clinic in Hanoi. Use the health survey to prepare for a consultation.
View the program → Program 02 · Skin preview openSee 18 image-based estimates after analysis. My page keeps your overall scores by date. Four-week comparisons are planned.
AI skin analysis → Program 03 · PlannedPlanned: refine separately consented records for research and clinical studies once partners and data arrangements are in place.
Learn more →For about two decades, stem-cell-based regenerative care has been costly and open to only a few. The barrier was never only science — it was access.
Not a market problem.
A barrier problem.
Stem cells are isolated from the umbilical cord lining (CellResearch Corp, published research). Discarded tissue becomes a raw material for regenerative medicine.
The science advanced. Access stayed narrow — reserved for the few who could afford the door.
Cellumium brings the published research, partner program information and personal records into one place.
Cellumium separates who sets policy, what unlocks access, and who delivers care.
A foundation in Singapore is proposed to oversee token issuance and burn policy. Its incorporation and schedule are unconfirmed.
The proposed token would support membership tiers and access to partner programs. Terms will be published once confirmed.
Cellumigen runs the first partner program. Staking for future partners is still under review.
The network states the vision. The founding partner provides the proof — an operating business, not a roadmap.
Operates premium regenerative-care tours between Korea and Hanoi (Vaalbara) — the network’s first proof point.
Described as operating by the partner. We make no claims about treatment outcomes or efficacy.
Numbers will appear here only once verified.
Token payments, burns and on-chain reporting are in development. The conditions for each will be published once confirmed.
The proposal would let members pay partners with tokens. Eligibility and discounts are under review.
The design considers how partner service revenue could support the network.
One option would use a share of network revenue to buy and burn tokens. No allocation or schedule is set.
The proposal calls for a public record of burns and policy changes. The reporting method is under review.
This proposal may change. Implementation depends on the final policy and operating conditions.
We will publish the litepaper once facts, legal review and on-chain details are verified. Until then, nothing here is a final specification.